These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9432753)

  • 1. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
    Weisser H; Krieg M
    Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
    Tunn S; Hochstrate H; Grunwald I; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17 beta-hydroxysteroid oxidoreductase in epithelium and stroma of human prostate.
    Tunn S; Schulze H; Krieg M
    J Steroid Biochem Mol Biol; 1993 Jul; 46(1):91-101. PubMed ID: 7687861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H; Krieg M
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):49-55. PubMed ID: 9780029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential activities of androgen metabolizing enzymes in human prostate.
    Krieg M; Weisser H; Tunn S
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):395-400. PubMed ID: 7542902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M; Nass R; Tunn S
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
    Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
    J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH).
    Rennie PS; Bruchovsky N; McLoughlin MG; Batzold FH; Dunstan-Adams EE
    J Steroid Biochem; 1983 Jul; 19(1A):169-73. PubMed ID: 6193340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5 alpha-androstane-3 beta,17 beta-diol hydroxylating enzymes in stroma and epithelium of human benign prostatic hyperplasia (BPH).
    Tunn S; Claus S; Schulze H; Braun BE; Krieg M
    J Steroid Biochem; 1987 Sep; 28(3):257-65. PubMed ID: 2443760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5 alpha-reductase activity in epithelium and stroma of prostates from intact and castrated dogs treated with androstenedione, the aromatase inhibitor 1-methyl-1,4-androstadiene-3,17-dione, and cyproterone acetate.
    Tunn S; Hochstrate H; Habenicht UF; Krieg M
    Prostate; 1988; 12(3):243-53. PubMed ID: 2967468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
    Hudson RW; Wherrett D
    J Steroid Biochem; 1990 Feb; 35(2):231-6. PubMed ID: 1689784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol.
    Krieg M; Schlenker A; Voigt KD
    Prostate; 1985; 6(3):233-40. PubMed ID: 2581234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
    Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5 alpha-reductase inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H; Tunn S; Debus M; Krieg M
    Steroids; 1994 Nov; 59(11):616-20. PubMed ID: 7535480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benign prostatic hyperplasia--the outcome of age-induced alteration of androgen-estrogen balance?].
    Weisser H; Krieg M
    Urologe A; 1997 Jan; 36(1):3-9. PubMed ID: 9123678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo.
    Weisser H; Behnke B; Helpap B; Bach D; Krieg M
    Eur Urol; 1997; 31(1):97-101. PubMed ID: 9032543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the effect of cofactors on the 5 alpha-reductase and 3 alpha- and 3 beta-hydroxysteroid reductase activities in the hyperplastic human prostate.
    Lombardo ME; Hakky SI; Hall MK; Hudson PB
    J Urol; 1992 Nov; 148(5):1605-10. PubMed ID: 1279222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.